全外显子测序与定制捕获两阶段研究:发现10个与前列腺癌风险相关的新基因
本研究采用两阶段设计,第一阶段对491例有强家族史或侵袭性前列腺癌的患者和429例对照进行全外显子测序,第二阶段在2917例病例和1899例对照中定制捕获验证。结果检出11个已知前列腺癌相关基因和10个新基因,其中8个新基因主要与侵袭性前列腺癌风险相关。
要点
- 全外显子测序联合定制捕获可发现前列腺癌新风险基因。
- 10个新基因中8个主要与侵袭性前列腺癌风险相关。
- 选择强家族史或侵袭性病例可提高基因发现效率。
核心结论
- 基因测序有助于发现与前列腺癌相关的遗传变异。
- 选取强家族史或侵袭性前列腺癌患者可提高发现效率。
研究设计与样本
- 两阶段设计:第一阶段全外显子测序(491例病例和429例对照),第二阶段定制捕获在独立样本(2917例病例和1899例对照)中验证。
- 侵袭性基于Gleason评分、淋巴结状态、转移、肿瘤分期、诊断时PSA、全身复发和前列腺癌死亡时间的评分总和。
主要发现
- 检出11个既往报道的前列腺癌相关基因:ATM、BRCA2、HOXB13、FAM111A、EMSY、HNF1B、KLK3、MSMB、PCAT1、PRSS3和TERT。
- 发现10个新基因:PABPC1、QK1、FAM114A1、MUC6、MYCBP2、RAPGEF4、RNASEH2B、ULK4、XPO7和THAP3。
- 10个新基因中除PABPC1和ULK4外,主要与侵袭性前列腺癌风险相关。
临床怎么用
- 对强家族史或侵袭性前列腺癌患者可考虑基因检测以评估遗传风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Family history of prostate cancer (PCa) is a well-known risk factor, and both common and rare genetic variants are associated with the disease. OBJECTIVE: To detect new genetic variants associated with PCa, capitalizing on the role of family history and more aggressive PCa. DESIGN, SETTING, AND PARTICIPANTS: A two-stage design was used. In stage one, whole-exome sequencing was used to identify potential risk alleles among affected men with a strong family history of disease or with more aggressive disease (491 cases and 429 controls). Aggressive disease was based on a sum of scores for Gleason score, node status, metastasis, tumor stage, prostate-specific antigen at diagnosis, systemic recurrence, and time to PCa death. Genes identified in stage one were screened in stage two using a custom-capture design in an independent set of 2917 cases and 1899 controls. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Frequencies of genetic variants (singly or jointly in a gene) were compared between cases and controls. RESULTS AND LIMITATIONS: Eleven genes previously reported to be associated with PCa were detected (ATM, BRCA2, HOXB13, FAM111A, EMSY, HNF1B, KLK3, MSMB, PCAT1, PRSS3, and TERT), as well as an additional 10 novel genes (PABPC1, QK1, FAM114A1, MUC6, MYCBP2, RAPGEF4, RNASEH2B, ULK4, XPO7, and THAP3). Of these 10 novel genes, all but PABPC1 and ULK4 were primarily associated with the risk of aggressive PCa. CONCLUSIONS: Our approach demonstrates the advantage of gene sequencing in the search for genetic variants associated with PCa and the benefits of sampling patients with a strong family history of disease or an aggressive form of disease. PATIENT SUMMARY: Multiple genes are associated with prostate cancer (PCa) among men with a strong family history of this disease or among men with an aggressive form of PCa.
引用
- Schaid DJ, McDonnell SK, FitzGerald LM, et al. Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer. Eur Urol. 2020. PMID: 32800727. doi:10.1016/j.eururo.2020.07.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。